معرفی
Dr. Sarah Tarbox-Berry is a Lecturer in Psychiatry at Yale University School of Medicine, affiliated with the Connecticut Mental Health Center. Her research focuses on schizophrenia and related psychotic disorders, particularly examining social functioning deficits, genetic and developmental markers of psychosis risk, and early intervention strategies for clinical high-risk populations. She holds a PhD in Clinical Psychology from the University of Pittsburgh and completed postdoctoral training in functional disability interventions at Yale.
Her research interests include:
- Identifying clinical and developmental markers predicting schizophrenia
- Genetic and environmental influences on psychosis risk
- Social cognition and interpersonal functioning in at-risk youth
- Optimizing risk assessment tools for early psychosis detection
Notable awards include the NARSAD Young Investigator Award (2013 & 2011) and multiple grants supporting her work on psychopathology and genetic mechanisms. She leads studies examining social deficits in high-risk youth and genetic correlates of psychosis onset.
Dr. Tarbox-Berry's clinical work involves the PRIME Prodromal Research Clinic, focusing on early psychosis intervention. Her interdisciplinary approach integrates behavioral, genetic, and clinical data to advance understanding of schizophrenia's developmental pathways.
